Pancreatic ductal carcinoma (PDAC) is one of the leading causes of cancer-related death worldwide. Computed tomography (CT) remains the primary imaging modality for diagnosis of PDAC. However, CT has limitations for early pancreatic tumor detection and tumor characterization so that it is currently challenged by magnetic resonance imaging. More recently, a particular attention has been given to radiomics for the characterization of pancreatic lesions using extraction and analysis of quantitative imaging features. In addition, radiomics has currently many applications that are developed in conjunction with artificial intelligence (AI) with the aim of better characterizing pancreatic lesions and providing a more precise assessment of tumor burden. This review article sums up recent advances in imaging of PDAC in the field of image/data acquisition, tumor detection, tumor characterization, treatment response evaluation, and preoperative planning. In addition, current applications of radiomics and AI in the field of PDAC are discussed.
BrayFFerlayJSoerjomataramISiegelRLTorreLAJemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424.
2.
LeonhardtCSNiesenWKalkumE, et al.Prognostic relevance of the revised R status definition in pancreatic cancer: Meta-analysis. BJS Open. 2022;6:zrac010.
3.
BluemkeDACameronJLHrubanRH, et al.Potentially resectable pancreatic adenocarcinoma: Spiral CT assessment with surgical and pathologic correlation. Radiology. 1995;197:381-385.
4.
RheeHParkMS. The role of imaging in current treatment strategies for pancreatic adenocarcinoma. Korean J Radiol. 2021;22:23-40.
5.
HarringtonKAShukla-DaveAPaudyalRDoRKG. MRI of the pancreas. J Magn Reson Imaging. 2021;53:347-359.
6.
WeisbergEMChuLCParkS, et al.Deep lessons learned: Radiology, oncology, pathology, and computer science experts unite around artificial intelligence to strive for earlier pancreatic cancer diagnosis. Diagn Interv Imaging. 2020;101:111-115.
7.
AzoulayACrosJVulliermeMP, et al.Morphological imaging and CT histogram analysis to differentiate pancreatic neuroendocrine tumor grade 3 from neuroendocrine carcinoma. Diagn Interv Imaging. 2020;101:821-830.
8.
NakauraTHigakiTAwaiKIkedaOYamashitaY. A primer for understanding radiology articles about machine learning and deep learning. Diagn Interv Imaging. 2020;101:765-770.
9.
BaratMChassagnonGDohanA, et al.Artificial intelligence: A critical review of current applications in pancreatic imaging. Jpn J Radiol. 2021;39:514-523.
LyuPNeelyBSolomonJ, et al.Effect of deep learning image reconstruction in the prediction of resectability of pancreatic cancer: Diagnostic performance and reader confidence. Eur J Radiol. 2021;141:109825.
12.
GreffierJDabliDHamardA, et al.Impact of dose reduction and the use of an advanced model-based iterative reconstruction algorithm on spectral performance of a dual-source CT system: A task-based image quality assessment. Diagn Interv Imaging. 2021;102:405-412.
13.
NagayamaYTanoueSInoueT, et al.Dual-layer spectral CT improves image quality of multiphasic pancreas CT in patients with pancreatic ductal adenocarcinoma. Eur Radiol. 2020;30:394-403.
14.
NodaYGoshimaSKagaT, et al.Virtual monochromatic image at lower energy level for assessing pancreatic ductal adenocarcinoma in fast kV-switching dual-energy CT. Clin Radiol. 2020;75:320.e17-320.e23.
15.
NodaYGoshimaSMiyoshiT, et al.Assessing chemotherapeutic response in pancreatic ductal adenocarcinoma: Histogram analysis of iodine concentration and CT number in single-source dual-energy CT. AJR Am J Roentgenol. 2018;211:1221-1226.
16.
ChaikaMAfatSWesslingD, et al.Deep learning-based super-resolution gradient echo imaging of the pancreas: Improvement of image quality and reduction of acquisition time. Diagn Interv Imaging2022. doi:10.1016/j.diii.2022.06.006.
17.
TajimaTAkaiHYasakaK, et al.Clinical feasibility of an abdominal thin-slice breath-hold single-shot fast spin echo sequence processed using a deep learning-based noise-reduction approach. Magn Reson Imaging. 2022;90:76-83.
18.
Marion-AudibertAMVulliermeMP, et al.Routine MRI with DWI sequences to detect liver metastases in patients with potentially resectable pancreatic ductal carcinoma and normal liver CT: A prospective multicenter study. AJR Am J Roentgenol. 2018;211:W217-W225.
19.
ToftJHaddenWJLaurenceJM, et al.Imaging modalities in the diagnosis of pancreatic adenocarcinoma: A systematic review and meta-analysis of sensitivity, specificity and diagnostic accuracy. Eur J Radiol. 2017;92:17-23.
20.
BarralMTaouliBGuiuBKohDMLucianiAManfrediR. Diffusion-weighted MR imaging of the pancreas: Current status and recommendations. Radiology. 2015;274:45-63.
21.
De RobertisRCardobiNOrtolaniS, et al.Intravoxel incoherent motion diffusion-weighted MR imaging of solid pancreatic masses: Reliability and usefulness for characterization. Abdom Radiol. 2019;44:131-139.
22.
ZengPMaLLiuJSongZYuanH. The diagnostic value of intravoxel incoherent motion diffusion-weighted imaging for distinguishing nonhypervascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas. Eur J Radiol. 2022;150:110261.
23.
MaWZhangGRenJ, et al.Quantitative parameters of intravoxel incoherent motion diffusion weighted imaging (IVIM-DWI): Potential application in predicting pathological grades of pancreatic ductal adenocarcinoma. Quant Imaging Med Surg. 2018;8:301-310.
24.
ChuLCParkSKawamotoS, et al.Application of deep learning to pancreatic cancer detection: Lessons learned from our initial experience. J Am Coll Radiol. 2019;16:1338-1342.
25.
MahmoudiTKouzahkananZMRadmardAR, et al.Segmentation of pancreatic ductal adenocarcinoma (PDAC) and surrounding vessels in CT images using deep convolutional neural networks and texture descriptors. Sci Rep. 2022;12:3092.
26.
ToshimaFWatanabeRInoueD, et al.CT abnormalities of the pancreas associated with the subsequent diagnosis of clinical stage I pancreatic ductal adenocarcinoma more than 1 year later: A case-control study. AJR Am J Roentgenol. 2021;217:1353-1364.
27.
LiuSLLiSGuoYT, et al.Establishment and application of an artificial intelligence diagnosis system for pancreatic cancer with a faster region-based convolutional neural network. Chin Med J. 2019;132:2795-2803.
28.
LiuKLWuTChenPT, et al.Deep learning to distinguish pancreatic cancer tissue from non-cancerous pancreatic tissue: A retrospective study with cross-racial external validation. Lancet Digital Health. 2020;2:e303-e313.
29.
MaHLiuZXZhangJJ, et al.Construction of a convolutional neural network classifier developed by computed tomography images for pancreatic cancer diagnosis. World J Gastroenterol. 2020;26:5156-5168.
30.
MukherjeeSPatraAKhasawnehH, et al.Radiomics-based machine-learning models can detect pancreatic cancer on pediagnostic CTs at a pubstantial lead time prior to clinical diagnosis. Gastroenterology2022. doi:10.1053/j.gastro.2022.06.066.
31.
GirardRDjelouahMBaratM, et al.Abdominal metastases from Merkel cell carcinoma: Prevalence and presentation on CT examination in 111 patients. Diagn Interv Imaging. 2022;103:41-48.
32.
BaratMAldhaheriRDohanA, et al.Utility of CT to differentiate pancreatic parenchymal metastasis from pancreatic ductal adenocarcinoma. Cancers. 2021;13:3103.
33.
AldhaheriRBaratMDohanA, et al.Imaging features of undifferentiated carcinoma with osteoclastic giant cells of the pancreas. Diagn Interv Imaging. 2020;101:839-841.
34.
LiJLuJLiangP, et al.Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers. Cancer Med. 2018;7:4924-4931.
35.
ParkSChuLCHrubanRH, et al.Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features. Diagn Interv Imaging. 2020;101:555-564.
36.
BartoliMBaratMDohanA, et al.CT and MRI of pancreatic tumors: An update in the era of radiomics. Jpn J Radiol. 2020;38:1111-1124.
37.
ChuLCParkSKawamotoS, et al.Utility of CT radiomics features in differentiation of pancreatic ductal adenocarcinoma from normal pancreatic tissue. AJR Am J Roentgenol. 2019;213:349-357.
38.
RenSZhangJChenJ, et al.Evaluation of texture analysis for the differential diagnosis of mass-forming pancreatitis from pancreatic ductal adenocarcinoma on contrast-enhanced CT images. Front Oncol. 2019;9:1171.
39.
RenSTangHJZhaoR, et al.Application of unenhanced computed tomography texture analysis to differentiate pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma. Curr Med Sci. 2022;42:217-225.
40.
GuoCZhugeXWangQ, et al.The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: The values of CT imaging features and texture analysis. Cancer Imaging. 2018;18:37.
41.
HuangZLiMHeD, et al.Two-dimensional texture analysis based on CT images to differentiate pancreatic lymphoma and pancreatic adenocarcinoma: A preliminary study. Acad Radiol. 2019;26:e189-e195.
42.
ZiegelmayerSKaissisGHarderF, et al.Deep convolutional neural network-assisted feature extraction for diagnostic discrimination and feature visualization in pancreatic ductal adenocarcinoma versus autoimmune pancreatitis. J Clin Med. 2020;9:4013.
43.
MengYZhangHLiQ, et al.Noncontrast magnetic resonance radiomics and multilayer perceptron network classifier: An approach for predicting fibroblast activation protein expression in patients with pancreatic ductal adenocarcinoma. J Magn Reson Imaging. 2021;54:1432-1443.
44.
ZhuLShiXXueH, et al.CT imaging biomarkers predict clinical outcomes after pancreatic cancer surgery. Medicine. 2016;95:e2664.
45.
CassinottoCChongJZogopoulosG, et al.Resectable pancreatic adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting pathology and patient outcomes. Eur J Radiol. 2017;90:152-158.
46.
YunGKimYHLeeYJ, et al.Tumor heterogeneity of pancreas head cancer assessed by CT texture analysis: Association with survival outcomes after curative resection. Sci Rep. 2018;8:7226.
47.
ChakrabortyJLangdon-EmbryLCunananKM, et al.Preliminary study of tumor heterogeneity in imaging predicts two-year survival in pancreatic cancer patients. PLoS One. 2017;12:e0188022.
48.
AttiyehMAChakrabortyJDoussotA, et al.Survival prediction in pancreatic ductal adenocarcinoma by quantitative computed tomography image analysis. Ann Surg Oncol. 2018;25:1034-1042.
49.
EilaghiABaigSZhangY, et al.CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma: A quantitative analysis. BMC Med Imaging. 2017;17:38.
50.
KimHSKimYJKimKGParkJS. Preoperative CT texture features predict prognosis after curative resection in pancreatic cancer. Sci Rep. 2019;9:17389.
51.
ParkSShamJGKawamotoS, et al.CT radiomics-based preoperative survival prediction in patients with pancreatic ductal adenocarcinoma. AJR Am J Roentgenol. 2021;217:1104-1112.
52.
GaoYChengSZhuL, et al.A systematic review of prognosis predictive role of radiomics in pancreatic cancer: Heterogeneity markers or statistical tricks?Eur Radiol. Epub ahead of print 2022. doi:10.1007/s00330-022-08922-0
53.
ChoiMHLeeYJYoonSB, et al.MRI of pancreatic ductal adenocarcinoma: Texture analysis of T2-weighted images for predicting long-term outcome. Abdom Radiol. 2019;44:122-130.
54.
TangTYLiXZhangQ, et al.Development of a novel multiparametric MRI radiomic nomogram for preoperative evaluation of early recurrence in resectable pancreatic cancer. J Magn Reson Imaging. 2019;52:231-245.
55.
KaissisGZiegelmayerSLohöferF, et al.A machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma from preoperative diffusion-weighted imaging. Eur Radiol Exp. 2019;3:41.
56.
McClaineRJLowyAMSussmanJJ, et al.Neoadjuvant therapy may lead to successful surgical resection and improved survival in patients with borderline resectable pancreatic cancer. HPB. 2010;12:73-79.
57.
CassinottoCCortadeJBelleannéeG, et al.An evaluation of the accuracy of CT when determining resectability of pancreatic head adenocarcinoma after neoadjuvant treatment. Eur J Radiol. 2013;82:589-593.
58.
ChenXOshimaKSchottD, et al.Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory study. PLoS One. 2017;12:e0178961.
59.
KimBRKimJHAhnSJ, et al.CT prediction of resectability and prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment using image findings and texture analysis. Eur Radiol. 2019;29:362-372.
60.
CiaravinoVCardobiNDe RobertisR, et al.CT Texture analysis of ductal adenocarcinoma downstaged after chemotherapy. Anticancer Res. 2018;38:4889-4895.
61.
WatsonMDBaimas-GeorgeMRMurphyKJ, et al.Pure and hybrid deep learning models can predict pathologic tumor response to neoadjuvant therapy in pancreatic adenocarcinoma: A pilot study. Am Surg. 2021;87:1901-1909.
62.
SandrasegaranKLinYAsare-SawiriMTaiyiniTTannM. CT texture analysis of pancreatic cancer. Eur Radiol. 2019;29:1067-1073.
63.
CozziLComitoTFogliataA, et al.Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma. PLoS One. 2019;14:e0210758.
64.
ChengSHChengYJJinZYXueHD. Unresectable pancreatic ductal adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting outcomes of patients treated with chemotherapy. Eur J Radiol. 2019;113:188-197.
65.
Salinas-MirandaEKhalvatiFNamdarK, et al.Validation of prognostic radiomic features from resectable pancreatic ductal adenocarcinoma in patients with advanced disease undergoing chemotherapy. Can Assoc Radiol J. 2021;72:605-613.
66.
JooILeeJMLeeES, et al.Preoperative CT classification of the resectability of pancreatic cancer: Interobserver agreement. Radiology. 2019;293:343-349.
67.
KimHYLeeYJChangW, et al.Tumor resectability and response on CT following neoadjuvant therapy for pancreatic cancer: Inter-observer agreement study. Eur Radiol. 2022;32:3799-3807.
68.
ParkJHYoonYSLeeS, et al.Diagnostic accuracy of CT for evaluating circumferential resection margin status in resectable or borderline resectable pancreatic head cancer: A prospective study using axially sliced surgical pathologic correlation. Korean J Radiol. 2022;23:322-332.
69.
NodaYKawaiNKagaT, et al.Vascular involvement and resectability of pancreatic ductal adenocarcinoma on contrast-enhanced MRI: Comparison with pancreatic protocol CT. Abdom Radiol. 2022;47:2835-2844.
70.
RigiroliFHoyeJLereboursR, et al.CT radiomic features of superior mesenteric artery involvement in pancreatic ductal adenocarcinoma: A pilot study. Radiology. 2021;301:610-622.
71.
BianYJiangHMaC, et al.Performance of CT-based radiomics in diagnosis of superior mesenteric vein resection margin in patients with pancreatic head cancer. Abdom Radiol. 2020;45:759-773.
72.
ElsherifSBJavadiSLeO, et al.Baseline CT-based radiomic features aid prediction of nodal positivity after neoadjuvant therapy in pancreatic cancer. Radiol Imaging Cancer. 2022;4:e210068.
73.
SakaguchiTValenteRTanakaKSatoiSDel ChiaroM. Surgical treatment of metastatic pancreatic ductal adenocarcinoma: A review of current literature. Pancreatology. 2019;19:672-680.
74.
AlabousiMMcInnesMDSalamehJP, et al.MRI vs. CT for the detection of liver metastases in patients with pancreatic carcinoma: A comparative diagnostic test accuracy systematic review and meta-analysis. J Magn Reson Imaging. 2021;53:38-48.
75.
AissaouiMLupoACoriatR, et al.CT features of lung metastases from pancreatic adenocarcinoma: Correlation with histopathologic findings. Diagn Interv Imaging. 2021;102:371-377.
76.
MehtsunWTChipidzaFEFernández-Del CastilloC, et al.Are staging computed tomography scans of the chest necessary in pancreatic adenocarcinoma?Ann Surg Oncol. 2018;25:3936-3942.
77.
KuanLLDennisonARGarceaG. Significance of indeterminate pulmonary nodules in resectable pancreatic adenocarcinoma-a review. Langenbecks Arch Surg. 2021;406:537-545.
78.
SukerMGroot KoerkampBNuyttensJJ, et al.The yield of chest computed tomography in patients with locally advanced pancreatic cancer. J Surg Oncol. 2020;122:450-456.
79.
Al-SaeediMSauerHBRamouzA, et al. Celiac axis stenosis is an underestimated risk factor for increased morbidity after pancreatoduodenectomy. Ann Surg2022. doi:10.1097/SLA.0000000000005383.
80.
GuptaAPKawamotoSJavedAA, et al.Perioperative CT angiography assessment of locally advanced distal pancreatic carcinoma to evaluate feasibility of the modified Appleby procedure. Eur J Radiol. 2020;131:109248.
81.
JavedAAYoungRWCHabibJR, et al.Cinematic rendering: Novel tool for improving pancreatic cancer surgical planning. Curr Probl Diagn Radiol2022. doi:10.1067/j.cpradiol.2022.04.001.
82.
AkkusATAtalaySABayraktutanU. Median arcuate ligament syndrome in association with celiomesenteric trunk. Diagn Interv Imaging. 2022;103:381-382.
83.
FishmanEK. CT scanning and data post-processing with 3D and 4D reconstruction: Are we there yet?Diagn Interv Imaging. 2020;101:691-692.
84.
PalmieriLJCoriatR. 18F-FDG PET/CT in pancreatic adenocarcinoma: On the edge of a paradigm shift?Diagn Interv Imaging. 2019;100:731-733.
